Rating History for 7/7/2026
| Company (Firm - Analyst) | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details | ||
|---|---|---|---|---|---|---|---|---|---|
| AbCellera Biologics
(Benchmark - Robert Wasserman) |
ABCL | Upgrade | Buy (Hold) |
11.00 (N/A) |
7.87 (11.37) |
44.47% | Details | ||
| Acadia Pharmaceuticals
(RBC Capital - Brian Abrahams) |
ACAD | Maintain | Outperform (N/A) |
36.00 (29.00) |
|
Details | |||
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 388 more... | |||||||||
